Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01845220 · ClinicalTrials.gov registry record · Phase 2
Prevention of Alcohol Intolerance
A Phase 2 study of Alcohol Sensitivity, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01845220 is a Phase 2 study of Alcohol Sensitivity that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01845220, a Phase 2 study of Alcohol Sensitivity, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to determine whether Asians who are especially sensitive to alcohol exposure can be protected by boosting their activities of an alcohol disposing enzyme. This will be accomplished by administering broccoli sprouts that are rich in an agent that increases protective enzyme activity. The test system involves applying alcohol patches to the skin and measuring skin redness.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Broccoli Sprout Extract
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-07-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01845220
The ClinicalTrials.gov registry entry for NCT01845220 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcohol Sensitivity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01845220 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01845220 about?
NCT01845220 is a clinical study titled "Prevention of Alcohol Intolerance". This study is designed to determine whether Asians who are especially sensitive to alcohol exposure can be protected by boosting their activities of an alcohol disposing enzyme. This will be accomplished by administering broccoli sprouts that are rich in an agent that increases protective enzyme act...
What is the current status of trial NCT01845220?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2014-04. Estimated completion is 2015-07-01.
What conditions does trial NCT01845220 study?
This clinical trial studies the following conditions: Alcohol Sensitivity.
What interventions are being tested in trial NCT01845220?
The interventions under investigation include: Placebo (DRUG), Broccoli Sprout Extract (DRUG).
Who is sponsoring clinical trial NCT01845220?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01845220 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.